The European Food Safety Authority has given a green light to a genetically modified food enzyme, potentially opening the door for its commercial use in Europe's bakery sector while setting the stage for debates about biotechnology in food processing. Published on March 31, 2026, this scientific opinion from EFSA's Panel on Food Contact Materials, Enzymes and Processing Aids represents a crucial regulatory step that will impact food manufacturers, biotechnology firms, and consumer groups across the EU.
Document Details and Regulatory Nature This scientific opinion published in the EFSA Journal on March 31, 2026, comes from EFSA's specialized scientific panel. The document provides a non-binding scientific assessment that will inform subsequent regulatory decisions by the European Commission and member states. It contains concrete scientific findings with specific numerical safety thresholds, including a dietary exposure estimate of 0.609 mg TOS/kg body weight per day and a margin of exposure calculation of at least 1993.
Policy Direction and Trade-offs The assessment prioritizes scientific risk assessment over precautionary restrictions, moving toward allowing genetically modified food enzymes in the EU market. This represents a shift from precautionary biotechnology skepticism toward evidence-based regulation, balancing innovation in food processing technology against consumer safety concerns. The document favors market access for biotechnology products over maintaining strict genetic modification barriers, provided safety thresholds are met.
Impact on Stakeholders For Genencor International B.V., the enzyme producer, this represents a major market opportunity with potential access to the EU's bakery sector, though they face ongoing compliance costs and regulatory scrutiny. EU bakery manufacturers gain access to potentially more efficient production technologies but must manage consumer perceptions about genetically modified ingredients. EU consumers benefit from potentially improved product quality and safety assurances, but some may have concerns about genetic modification in food processing. National food safety authorities face increased regulatory complexity in monitoring compliance with the new safety parameters.
Institutional Follow-up This scientific opinion initiates the regulatory approval process, with the European Commission and member states now expected to consider authorization based on EFSA's safety assessment. The document represents the beginning of a multi-stage process where political and regulatory bodies will make final decisions about market access, potentially triggering further public consultations and stakeholder debates.
← Atlas › News